Realeve develops miniaturized neurostimulation devices designed to set a new standard in treating severe headache.
Realeve develops miniaturized neurostimulation devices designed to set a new standard in treating severe headache. It focuses on the development and commercialization of innovative therapies for the treatment of autonomic disorders, particularly severe headache.The company was founded in 2007 and is headquartered in Mountain View, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 11, 2011 | Series C | $32M | 1 | — | — | Detail |
May 22, 2009 | Series B | $20M | 1 | Versant Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Versant Ventures | — | Series C |